Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors & Lymphomas
Clinical trial NCT00023166 · TERMINATED
Trial details
- NCT number
- NCT00023166
- Sponsor
- Enzon Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2001-05-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.